FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
-22.71%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$236M
AUM Growth
+$236M
(-29%)
Cap. Flow
-$21.8M
Cap. Flow
% of AUM
-9.24%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
OMGA
Omega Therapeutics, Inc. Common Stock
OMGA
|
$21.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Moderna
MRNA
$9.37B
| $131M | 55.7% |
4,632,149
| – | – |
|
2
Foghorn Therapeutics
FHTX
$286M
| $46.3M | 19.62% |
12,674,120
| – | – |
|
3
Sana Biotechnology
SANA
$777M
| $42M | 17.82% |
25,001,856
| – | – |
|
4
Seres Therapeutics
MCRB
$166M
| $16.2M | 6.86% |
23,117,045
| – | – |
|
|
OMGA
5
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| – | – |
-29,225,579
| Closed | -$21.8M |
|